Bifilact

Bifilact is owned by Fidia Farmaceutici S.p.A., headquartered in Italy. No. The ultimate owner of Bifilact, Fidia Farmaceutici S.p.A., is headquartered in Italy, not in the United States.

An Italian multinational company specializing in the research, development, and production of hyaluronic acid-based products and specialized pharmaceuticals.